Peer-reviewedCC BY-NCJournal for immunotherapy of cancer15 Oct 2026

Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures.

Anran Sun^1,2
Hongkai Chen¹
Anyang Wei³

¹Department of Urology, The Third Affiliated Hospital of South China University of Technology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, China.
²Department of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
³Department of Urology, The Third Affiliated Hospital of South China University of Technology, Foresea Life Insurance Guangzhou General Hospital, Guangzhou, Guangdong, China [email protected].

Magnetic resonance imaging-based radiomics for predicting P53-mutated hepatocellular carcinoma: intratumoral and peritumoral analysis
Jingfei Weng, Dinghua Yao, Qihu Zeng +3
Translational cancer research13 Aug 2026Peer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
Research progress in intratumoral microbiota: unlocking the potential of cancer immunotherapy
Tian Tian, Min Chen
Frontiers in immunology1 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCCrossref
Intratumoral Immunotherapy-The Future of Treating Merkel Cell Carcinoma?
Nayonika Pande, Justin C Moser, Sanjay Chandrasekaran +3
Cancers7 Oct 2026Peer-reviewedCC BYFull textOncologyEurope PMCCrossref
Endoscopic ultrasound-guided intratumoral alpha radiotherapy: clinical implementation of a novel therapeutic delivery platform.
Corey S Miller, Magali Lecavalier-Barsoum, David Roberge +4
Endoscopy12 Oct 2026Peer-reviewedCC BYFull textMedical imaging & radiologyEurope PMC
Intratumoral Klebsiella pneumoniae drives metabolic-immune remodeling and immunotherapy resistance in bladder cancer
Ruilin Zhuang, Zhiming Wu, Runhao Zheng +10
Journal for Immunotherapy of Cancer27 Oct 2026Peer-reviewedCC BY-NC 4.0Full textOncologyPMC

Cite

BibTeX

@article{sun2026temporal,
  title = {{Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures.}},
  author = {Anran Sun and Hongkai Chen and Anyang Wei},
  journal = {Journal for immunotherapy of cancer},
  year = {2026},
  month = oct,
  doi = {10.1136/jitc-2026-016391},
  url = {https://europepmc.org/article/MED/42880821},
  note = {CC BY-NC},
}

RIS

TY  - JOUR
TI  - Temporal and therapeutic confounders in predicting efficacy of immunotherapy rechallenge via baseline intratumoral tertiary lymphoid structures.
AU  - Anran Sun
AU  - Hongkai Chen
AU  - Anyang Wei
PY  - 2026
DA  - 2026/10/15
JO  - Journal for immunotherapy of cancer
DO  - 10.1136/jitc-2026-016391
UR  - https://europepmc.org/article/MED/42880821
SN  - 2051-1426
ER  -

Related

Cite